Bladder Cancer Stage Development, 2004-2014 in Europe Compared With the United States: Analysis of European Population-based Cancer Registries, the United States SEER Database, and a Large Tertiary Institutional Cohort-Reference-Cited by-同舟云学术

Bladder Cancer Stage Development, 2004-2014 in Europe Compared With the United States: Analysis of European Population-based Cancer Registries, the United States SEER Database, and a Large Tertiary Institutional Cohort

Published:2020-06 Issue:3 Volume:18 Page:162-170.e4
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Schulz Gerald B.,Grimm Tobias,Buchner Alexander^ORCID,Jokisch Friedrich,Kretschmer Alexander,Stief Christian G.,Knüchel Ruth,Kraywinkel Klaus,Karl Alexander

Publisher

Elsevier BV

Reference49 articles.

1. Bladder cancer incidence and mortality: a global overview and recent trends;Antoni;Eur Urol,2017

2. Economic burden of bladder cancer across the European Union;Leal;Eur Urol,2016

3. Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer;Bochner;J Clin Oncol,2006

4. Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients;Hautmann;Eur Urol,2012

5. Why has the survival of patients with bladder cancer not improved?;Malmstrom;BJU Int,2008

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravesical BCG: A Double-Edged Sword? The Untold Story of Infection Risks;Medicina;2025-02-22

2. First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder Cancer;Journal of Clinical Oncology;2024-12-10

3. The Multi-Institutional Medullary Thyroid Cancer Collaborative Registry: Can a Rare Tumor Registry Accurately Represent the Real-World Patient Population?;Thyroid®;2024-09-01

4. Adverse drug reactions of intravesical instillation therapy for bladder cancer: based on FDA adverse event reporting system;Expert Opinion on Drug Safety;2024-08-22

5. Recent trends in incidence, mortality, survival, and treatment of upper tract urothelial carcinoma;The French Journal of Urology;2024-03